18-Feb-2026
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks (Wed, 18-Feb 11:00 AM ET)
Benzinga (Wed, 18-Feb 2:32 AM ET)
Business Wire (Tue, 17-Feb 9:00 AM ET)
GE HealthCare announces cash dividend for first quarter of 2026
Business Wire (Thu, 12-Feb 6:11 PM ET)
GE HealthCare management to present at upcoming investor conferences
Business Wire (Thu, 12-Feb 7:30 AM ET)
Business Wire (Mon, 9-Feb 8:00 AM ET)
GE HealthCare Delivers Strong 2025 Results: Free Cash Flow and Segment Gains Set Pace for 2026
Market Chameleon (Wed, 4-Feb 2:11 AM ET)
GE HealthCare reports fourth quarter and full year 2025 financial results
Business Wire (Wed, 4-Feb 6:20 AM ET)
Business Wire (Mon, 2-Feb 8:00 AM ET)
GE HealthCare Recommends Shareholders Reject "Mini-Tender" Offer by Potemkin Limited
Business Wire (Tue, 6-Jan 5:00 PM ET)
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ge Healthcare Techs trades on the NASDAQ stock market under the symbol GEHC.
As of February 18, 2026, GEHC stock price climbed to $82.95 with 2,095,608 million shares trading.
GEHC has a beta of 1.89, meaning it tends to be more sensitive to market movements. GEHC has a correlation of 0.66 to the broad based SPY ETF.
GEHC has a market cap of $37.78 billion. This is considered a Large Cap stock.
Last quarter Ge Healthcare Techs reported $6 billion in Revenue and $1.44 earnings per share. This beat revenue expectation by $99 million and exceeded earnings estimates by $.03.
In the last 3 years, GEHC traded as high as $94.80 and as low as $57.65.
The top ETF exchange traded funds that GEHC belongs to (by Net Assets): VTI, VOO, QQQ, VO, IVV.
GEHC has underperformed the market in the last year with a return of -9.9%, while SPY returned +13.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in GEHC shares. However, GEHC has outperformed the market in the last 3 month and 2 week periods, returning +17.5% and +5.3%, while SPY returned +3.4% and -0.5%, respectively. This indicates GEHC has been having a stronger performance recently.
GEHC support price is $80.08 and resistance is $83.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GEHC shares will trade within this expected range on the day.